DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial
ATN
Clinical Trial to Monitor the Clinical Effectiveness of the DePuy ATN Trochanteric Nailing System in the Treatment of Trochanteric Fractures of the Proximal Femur
1 other identifier
observational
62
1 country
4
Brief Summary
The purpose of this study is to monitor trochanteric fracture healing and review the performance of the ATN system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2006
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 17, 2007
CompletedFirst Posted
Study publicly available on registry
October 19, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedResults Posted
Study results publicly available
December 10, 2010
CompletedJune 6, 2023
June 1, 2023
3 years
October 17, 2007
September 29, 2010
June 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Success in Terms of the Merle D'Aubigne Postel Score for Pain Category
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months
Success in Terms of the Merle D'Aubigne Postel Score for Walk Category
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months
Success in Terms of the Merle D'Aubigne Postel Score for Mobility Category
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months
Secondary Outcomes (4)
Lower Extremity Measure (LEM)
4 weeks, 3, 6 and 12 months
Medical Imaging
4 weeks, 3, 6 and 12 months
Six Item Screener and Ambulatory Status
4 weeks, 3, 6 and 12 months
SF-12
4 weeks, 3, 6 and 12 months
Study Arms (1)
A
Monitoring of trochanteric fractures after treatment with the ATN system.
Interventions
Trochanteric nailing for proximal femoral fractures.
Eligibility Criteria
You may qualify if:
- Ability to understand and willing to sign the approved consent form.
- years of age
- Skeletally mature
- Have stable or unstable proximal femur fracture, including pertrochanteric, intertrochanteric, high subtrochanteric or any combination of the AO Proximal Femur Fracture Classification
You may not qualify if:
- Subjects with concomitant lower extremity injuries or multiple trauma that would interfere with normal hip fracture rehabilitation.
- Subjects who have isolated or combined medial femoral neck fractures.
- Subjects who are unwilling or unable to comply with a rehabilitation program or are unwilling or unable to be assessed for 1 year following surgery.
- Subjects who are pregnant or breastfeeding.
- Subjects who are a prisoner or a known alcohol or drug abuser.
- Subjects who have a prior surgical history in the affected hip, or conditions that may interfere with outcome or impede healing.
- Subjects who have an obliterated medullary canal or other conditions that may complicate the reaming process.
- Subjects who have evidence of active untreated infections that may spread to other areas of the body.
- Subjects who have a highly communicable disease or pathology that may limit follow-up.
- Subjects, who in the opinion of the Clinical Investigator, have an existing condition that indicates the Subject is not a good candidate for the study.
- Subjects who are participating in another clinical investigation.
- Subjects known to have allergies to titanium, aluminum, vanadium.
- Subjects who are currently eligible for workman's compensation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Front Range Orthopaedics
Colorado Springs, Colorado, 80910, United States
Orthopaedic Physicians of Colorado
Englewood, Colorado, 80110, United States
Erie County Medical Center
Buffalo, New York, 14215, United States
Blue Ridge Bone and Joint
Asheville, North Carolina, 28801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sam Himden
- Organization
- DePuy Orthopaedics, Inc.
Study Officials
- STUDY DIRECTOR
Sam Himden
DePuy Orthopaedics
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2007
First Posted
October 19, 2007
Study Start
September 1, 2006
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
June 6, 2023
Results First Posted
December 10, 2010
Record last verified: 2023-06